Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations. (PubMed, Ann Rheum Dis) - May 23, 2024 - "Anifrolumab and belimumab achieve better disease control than standard of care in extrarenal SLE, while combination therapies with belimumab and voclosporin attained higher response rates in high-quality RCTs in LN. Remission and low disease activity are associated with favourable long-term outcomes. In patients achieving these targets, GC and immunosuppressive therapy may gradually be tapered. Cite Now."
Journal • Review • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Herpes Zoster • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Novel Coronavirus Disease • Respiratory Diseases • Rheumatology • Systemic Lupus Erythematosus • Varicella Zoster • IFNAR2
|
|
Antonis Fanouriakis; Chetan B Mukhtyar; Dimitrios T Boumpas; George Bertsias; Myrto Kostopoulou
|